BRPI0813011A2 - Formulação injetável aquosa estéril, processo de preparação da mesma e sua utilização - Google Patents

Formulação injetável aquosa estéril, processo de preparação da mesma e sua utilização

Info

Publication number: BRPI0813011A2
Authority: BR; Brazil
Prior art keywords: preparation process; injectable formulation; water injectable; water; formulation
Prior art date: 2007-07-02

Application number

Other languages

English (en)

Inventor

Samuel Gavard Molliard

Olivier Benoit

Original Assignee

Anteis Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-02

Filing date

2008-07-02

Publication date

2014-12-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167393&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0813011(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-07-02 Application filed by Anteis Sa filed Critical Anteis Sa

2014-12-23 Publication of BRPI0813011A2 publication Critical patent/BRPI0813011A2/pt

2019-10-08 Publication of BRPI0813011B1 publication Critical patent/BRPI0813011B1/pt

2021-05-25 Publication of BRPI0813011B8 publication Critical patent/BRPI0813011B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Materials Engineering (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

BRPI0813011A 2007-07-02 2008-07-02 formulação injetável aquosa estéril, processo de preparação da mesma e sua utilização BRPI0813011B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0704772A FR2918276B1 (fr)	2007-07-02	2007-07-02	"utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
FR0704772		2007-07-02
PCT/FR2008/000948 WO2009024670A2 (fr)	2007-07-02	2008-07-02	Gel injectable d ' acide hyaluronique pour le traitement des degenerescences articulaires

Publications (3)

Publication Number	Publication Date
BRPI0813011A2 true BRPI0813011A2 (pt)	2014-12-23
BRPI0813011B1 BRPI0813011B1 (pt)	2019-10-08
BRPI0813011B8 BRPI0813011B8 (pt)	2021-05-25

Family

ID=39167393

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0813011A BRPI0813011B8 (pt)	2007-07-02	2008-07-02	formulação injetável aquosa estéril, processo de preparação da mesma e sua utilização

Country Status (14)

Country	Link
US (1)	US9138405B2 (pt)
EP (2)	EP3498262B1 (pt)
JP (1)	JP5517133B2 (pt)
KR (1)	KR20100028582A (pt)
CN (2)	CN104825482A (pt)
BR (1)	BRPI0813011B8 (pt)
CA (1)	CA2691600C (pt)
ES (2)	ES2898939T3 (pt)
FR (1)	FR2918276B1 (pt)
HU (1)	HUE056793T2 (pt)
PL (2)	PL2173324T3 (pt)
PT (2)	PT2173324T (pt)
TR (1)	TR201909779T4 (pt)
WO (1)	WO2009024670A2 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2945949B1 (fr)	2009-05-26	2011-05-13	Anteis Sa	Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
US8273725B2 (en)	2009-09-10	2012-09-25	Genzyme Corporation	Stable hyaluronan/steroid formulation
FR2954165B1 (fr)	2009-12-18	2012-01-13	Jean-Noel Thorel	Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes
JP5457238B2 (ja) *	2010-03-17	2014-04-02	電気化学工業株式会社	ヒアルロン酸及び／又はその塩の含有液の加熱滅菌方法
IT1402382B1 (it) *	2010-09-09	2013-09-04	Ibsa Inst Biochimique Sa	Complessi cooperativi ibridi di acido ialuronico
US8398611B2 (en)	2010-12-28	2013-03-19	Depuy Mitek, Inc.	Compositions and methods for treating joints
US8524662B2 (en)	2010-12-28	2013-09-03	Depuy Mitek, Llc	Compositions and methods for treating joints
US8455436B2 (en)	2010-12-28	2013-06-04	Depuy Mitek, Llc	Compositions and methods for treating joints
US20140038917A1 (en) *	2011-04-19	2014-02-06	Anteis S.A.	Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
US8623839B2 (en) *	2011-06-30	2014-01-07	Depuy Mitek, Llc	Compositions and methods for stabilized polysaccharide formulations
GB201118586D0 (en) *	2011-10-27	2011-12-07	Turzi Antoine	New A-PRP medical device, manufacturing machine and process
WO2013076162A1 (en) *	2011-11-21	2013-05-30	Université Libre de Bruxelles	Formulations useful in the treatment of osteoarticular diseases
WO2013076160A1 (en) *	2011-11-21	2013-05-30	Université Libre de Bruxelles	Sustained release formulations useful in the treatment of diseases
FR2991876B1 (fr)	2012-06-13	2014-11-21	Vivacy Lab	Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr)	2012-08-29	2014-12-26	Vivacy Lab	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
KR20150104202A (ko) *	2013-01-11	2015-09-14	카르빌란 테라퓨틱스, 인코포레이티드	히알루론산을 포함하는 안정화된 조성물
ES2837626T3 (es)	2013-07-10	2021-07-01	Matrix Biology Inst	Composiciones de hialuronano con alta elasticidad y usos de las mismas
KR101582380B1 (ko) *	2013-09-11	2016-01-05	주식회사 제네웰	손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
EP3074427B1 (en)	2013-11-25	2021-01-06	Deuteria Biomaterials, LLC	Deuterium-enriched hyaluronan
US9682099B2 (en)	2015-01-20	2017-06-20	DePuy Synthes Products, Inc.	Compositions and methods for treating joints
FR3032617B1 (fr) *	2015-02-16	2018-03-16	Kylane Laboratoires Sa	Procede de preparation d un hydrogel injectable; hydrogel obtenu; utilisation de l hydrogel obtenu
RU2727809C2 (ru)	2015-09-24	2020-07-24	Матрикс Байолэджи Инститьют	Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
CN105879124B (zh) *	2016-04-26	2019-03-19	华熙福瑞达生物医药有限公司	一种注射用左旋聚乳酸填充剂及其制备方法
KR101916193B1 (ko)	2016-08-25	2018-11-07	주식회사 파마리서치프로덕트	핵산 및 키토산을 포함하는 관절강 주사용 조성물
US10576099B2 (en)	2016-10-21	2020-03-03	Covidien Lp	Injectable scaffold for treatment of intracranial aneurysms and related technology
FR3063649B1 (fr)	2017-03-07	2021-05-21	Laboratoire De Rhumatologie Appliquee	Nouvelle solution visco-elastique et son utilisation en rhumatologie
CN111065423B (zh) *	2017-08-22	2022-04-12	莫比斯医疗有限公司	用于关节润滑的脂质体制剂
IT201800007683A1 (it)	2018-07-31	2020-01-31	Altergon Sa	Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati
WO2020111888A1 (ko) *	2018-11-30	2020-06-04	주식회사 엘지화학	히알루론산을 포함하는 활액보충재용 조성물
US20220088589A1 (en)	2019-01-21	2022-03-24	Eclipse Medcorp, Llc	Methods, Systems and Apparatus for Separating Components of a Biological Sample
US12007382B2 (en)	2019-10-31	2024-06-11	Crown Laboratories, Inc.	Systems, methods and apparatus for separating components of a sample
EP3854377A1 (fr) *	2020-01-22	2021-07-28	Laboratoires Genevrier Sas	Composition comprenant de l'acide hyaluronique et un polyol ou de carboxyméthylcellulose

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL80298A (en) *	1986-10-14	1993-01-31	Res & Dev Co Ltd	Eye drops
US5079236A (en) *	1987-05-27	1992-01-07	Hyal Pharmaceutical Corporation	Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
JP2756131B2 (ja) *	1987-07-01	1998-05-25	ジェネンテク，インコーポレイテッド	フィブリンの沈着または癒着の予防のための方法および治療学的組成物
US5095037B1 (en) *	1989-12-21	1995-12-19	Nissho Kk	Combined anti-inflammatory agent
JP2788340B2 (ja) *	1989-12-21	1998-08-20	株式会社ニッショー	炎症治療剤
CA2060223C (en) *	1991-02-12	1999-07-20	Clarence C. Lee	Injectable medical lubricating fluid composition and method of use
US7968110B2 (en) *	1992-02-11	2011-06-28	Merz Aesthetics, Inc.	Tissue augmentation material and method
IT1291291B1 (it) *	1997-04-30	1999-01-07	Chemedica Sa	Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare
EP1465596A1 (en) *	2002-01-18	2004-10-13	Control Delivery Systems, Inc.	Polymeric gel system for the controlled delivery of codrugs
WO2004073759A1 (en)	2003-02-19	2004-09-02	Aventis Pharmaceuticals Holdings Inc.	Composition and method for intradermal soft tissue augmentation
US20050208095A1 (en) *	2003-11-20	2005-09-22	Angiotech International Ag	Polymer compositions and methods for their use
FR2865737B1 (fr) *	2004-02-03	2006-03-31	Anteis Sa	Gel reticule biocompatible
US20050215516A1 (en) *	2004-03-29	2005-09-29	Claudio Bucolo	New free-radical scavenger containing viscoelastic composition, methods of use and package
CA2577022A1 (en) *	2004-08-13	2006-02-23	Angiotech International Ag	Compositions and methods using hyaluronic acid and hyluronidase inhibitors
WO2006067608A1 (en) *	2004-12-22	2006-06-29	Laboratoire Medidom S.A.	Aqueous formulations based on sodium hyaluronate for parenteral use
FR2895907B1 (fr) *	2006-01-06	2012-06-01	Anteis Sa	Gel viscoelastique a usage dermatologique
FR2909560B1 (fr)	2006-12-06	2012-12-28	Fabre Pierre Dermo Cosmetique	Gel d'acide hyaluronique pour injection intradermique

2007
- 2007-07-02 FR FR0704772A patent/FR2918276B1/fr active Active
2008
- 2008-07-02 ES ES19156054T patent/ES2898939T3/es active Active
- 2008-07-02 JP JP2010514043A patent/JP5517133B2/ja active Active
- 2008-07-02 HU HUE19156054A patent/HUE056793T2/hu unknown
- 2008-07-02 ES ES08827889T patent/ES2735376T3/es active Active
- 2008-07-02 KR KR20097027301A patent/KR20100028582A/ko not_active Application Discontinuation
- 2008-07-02 TR TR2019/09779T patent/TR201909779T4/tr unknown
- 2008-07-02 EP EP19156054.9A patent/EP3498262B1/fr active Active
- 2008-07-02 PL PL08827889T patent/PL2173324T3/pl unknown
- 2008-07-02 PT PT08827889T patent/PT2173324T/pt unknown
- 2008-07-02 WO PCT/FR2008/000948 patent/WO2009024670A2/fr active Application Filing
- 2008-07-02 CN CN201510090635.XA patent/CN104825482A/zh active Pending
- 2008-07-02 PL PL19156054T patent/PL3498262T3/pl unknown
- 2008-07-02 US US12/667,627 patent/US9138405B2/en active Active
- 2008-07-02 EP EP08827889.0A patent/EP2173324B1/fr active Active
- 2008-07-02 CN CN200880023126A patent/CN101686936A/zh active Pending
- 2008-07-02 PT PT191560549T patent/PT3498262T/pt unknown
- 2008-07-02 CA CA2691600A patent/CA2691600C/fr active Active
- 2008-07-02 BR BRPI0813011A patent/BRPI0813011B8/pt active IP Right Grant

Also Published As

Publication number	Publication date
EP2173324A2 (fr)	2010-04-14
EP3498262A1 (fr)	2019-06-19
HUE056793T2 (hu)	2022-03-28
US20100184720A1 (en)	2010-07-22
CN104825482A (zh)	2015-08-12
PT2173324T (pt)	2019-07-09
CA2691600C (fr)	2017-01-10
EP3498262B1 (fr)	2021-09-01
KR20100028582A (ko)	2010-03-12
TR201909779T4 (tr)	2019-07-22
FR2918276B1 (fr)	2010-01-22
US9138405B2 (en)	2015-09-22
WO2009024670A3 (fr)	2009-04-23
FR2918276A1 (fr)	2009-01-09
CN101686936A (zh)	2010-03-31
ES2735376T3 (es)	2019-12-18
ES2898939T3 (es)	2022-03-09
PL2173324T3 (pl)	2019-09-30
CA2691600A1 (fr)	2009-02-26
WO2009024670A2 (fr)	2009-02-26
PT3498262T (pt)	2021-11-11
EP2173324B1 (fr)	2019-04-10
JP5517133B2 (ja)	2014-06-11
JP2010531863A (ja)	2010-09-30
PL3498262T3 (pl)	2022-02-07
BRPI0813011B8 (pt)	2021-05-25
BRPI0813011B1 (pt)	2019-10-08

Publication	Publication Date	Title
BRPI0813011A2 (pt)	2014-12-23	Formulação injetável aquosa estéril, processo de preparação da mesma e sua utilização
BRPI0905663A2 (pt)	2015-07-07	"emulsão estável, processo de preparação da emulsão estável e uso emulsão"
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI0918652A2 (pt)	2015-08-25	Composições farmacêuticas e métodos de libração relacionadas.
BRPI1009481A2 (pt)	2016-03-01	compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos
BRPI0821077A2 (pt)	2014-09-30	Formulação em gel
BRPI0914155A2 (pt)	2015-10-20	preparações de xampu
BRPI0920955A2 (pt)	2016-01-05	processo para a preparação de uma composição polimérica , composição polimérica, misturas, e, uso da composição polimérica
BRPI0907453A2 (pt)	2015-07-14	Compostos, uso e preparação dos mesmos
BR112012006404A2 (pt)	2016-04-12	derivados de di-hidropteridinona, processo de preparação e uso farmacêutico dos mesmos
BRPI0821801A2 (pt)	2015-07-14	Zeólito e processo de preparação de um zeólito.
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
DK2125048T3 (da)	2014-10-13	Præparat
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
BRPI0817575A2 (pt)	2015-04-07	Conjunto de rede de termocura de policicloolefina
BRPI0914152A2 (pt)	2015-10-20	preparações de xampu
BRPI0914063A2 (pt)	2015-11-03	composição de xampu concentrado
BRPI0807905A2 (pt)	2014-06-17	Composições medicinais aperfeiçoadas compreendendo buprenorfina e naloxona.
DK2173831T3 (da)	2012-09-17	Brøndbehandling
BRPI0812434A2 (pt)	2014-09-30	Gel de fibra de frutas
BRPI0812107A2 (pt)	2014-11-25	Formulação de duloxetina
BRPI0915527A2 (pt)	2016-01-26	pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BRPI1011822A2 (pt)	2016-03-29	"compostos de 3-substituída-8-substituída-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-ona e sua aplicação"
BRPI0914182A2 (pt)	2019-09-24	composto, e, composição farmacêutica

Legal Events

Date	Code	Title	Description
2016-06-14	B25A	Requested transfer of rights approved	Owner name: APTISSEN SA (CH)
2016-06-28	B25D	Requested change of name of applicant approved	Owner name: APTISSEN SA (CH)
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-08	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-06-05	B06I	Publication of requirement cancelled [chapter 6.9 patent gazette]
2018-07-03	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-12-04	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-04-02	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-07-30	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-10-08	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/07/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF